MALVERN, Pa.--(BUSINESS WIRE)--Dec. 5, 2005--Orthovita announced today that it has submitted a PMA for VITAGEL(TM) Surgical Hemostat to the FDA. FDA approval of the PMA submitted by Orthovita will allow Orthovita to sell VITAGEL product that is manufactured on-site at its Malvern, PA facility. Orthovita has been distributing VITAGEL since January, 2005 through a distribution agreement with Angiotech Pharmaceuticals. Orthovita will continue to distribute VITAGEL product made to date by Angiotech Biomaterials (a division of Angiotech Pharmaceuticals) until Orthovita receives FDA approval for its own PMA, which approval is expected in the second half of 2006.
